Pediatricians' Experiences With and Perceptions of the Vaccines for Children Program
- PMID: 32086388
- PMCID: PMC10206937
- DOI: 10.1542/peds.2019-1207
Pediatricians' Experiences With and Perceptions of the Vaccines for Children Program
Abstract
Background and objectives: The Vaccines for Children Program (VFC) provides vaccines for children who may not otherwise be vaccinated because of financial barriers. Pediatrician participation is crucial to the VFC's ongoing success. Our objectives were to assess, among a national sample of pediatricians, (1) VFC program participation, (2) perceived burden versus benefit of participation, and (3) knowledge and perception of a time-limited increased payment for VFC vaccine administration under the Patient Protection and Affordable Care Act.
Methods: An electronic and mail survey was conducted from June 2017 to September 2017.
Results: Response rate was 79% (372 of 471); 86% of pediatricians reported currently participating in the VFC; among those, 85% reported never having considered stopping, 10% considered it but not seriously, and 5% seriously considered it. Among those who had considered no longer participating (n = 47), the most commonly reported reasons included difficulty meeting VFC record-keeping requirements (74%), concern about action by the VFC for noncompliance (61%), and unpredictable VFC vaccine supplies (59%). Participating pediatricians rated, on a scale from -5 (high burden) to +5 (high benefit), their overall perception of the VFC: 63% reported +4 or +5, 23% reported +1 to +3, 5% reported 0, and 9% reported -1 to -5. Of pediatricians, 39% reported awareness of temporary increased payment for VFC vaccine administration. Among those, 10% reported that their practice increased the proportion of Medicaid and/or VFC-eligible patients served on the basis of this change.
Conclusions: For most pediatricians, perceived benefits of VFC participation far outweigh perceived burdens. To ensure the program's ongoing success, it will be important to monitor factors influencing provider participation.
Copyright © 2020 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Figures
Similar articles
-
Vaccines for Children program, United States, 1997.Pediatrics. 1999 Aug;104(2):e15. doi: 10.1542/peds.104.2.e15. Pediatrics. 1999. PMID: 10429133
-
Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation?Matern Child Health J. 2013 May;17(4):609-15. doi: 10.1007/s10995-012-1036-5. Matern Child Health J. 2013. PMID: 22569945 Free PMC article.
-
The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program.Pediatrics. 2005 Jul;116(1):130-9. doi: 10.1542/peds.2004-1058. Pediatrics. 2005. PMID: 15995043
-
Factors associated with pediatricians' participation in Medicaid in North Carolina.JAMA. 1992 Apr 8;267(14):1942-6. JAMA. 1992. PMID: 1296580
-
Improved timing of availability and administration of influenza vaccine through the US Vaccines for Children Program from 2007 to 2011.Clin Pediatr (Phila). 2013 Mar;52(3):224-30. doi: 10.1177/0009922812470868. Epub 2013 Jan 8. Clin Pediatr (Phila). 2013. PMID: 23299840
Cited by
-
Coronavirus Disease-2019 Vaccine Hesitancy.Pediatr Clin North Am. 2023 Apr;70(2):243-257. doi: 10.1016/j.pcl.2022.12.001. Epub 2022 Dec 8. Pediatr Clin North Am. 2023. PMID: 36841593 Free PMC article. Review.
-
Provision of Pediatric Immunization Services During the COVID-19 Pandemic: an Assessment of Capacity Among Pediatric Immunization Providers Participating in the Vaccines for Children Program - United States, May 2020.MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):859-863. doi: 10.15585/mmwr.mm6927a2. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32644980 Free PMC article.
References
-
- Santoli JM, Rodewald LE, Maes EF, Battaglia MP, Coronado VG. Vaccines for Children program, United States, 1997. Pediatrics. 1999;104(2):e15. - PubMed
-
- Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (London, England). 2006;367(9518):1247–1255. - PubMed
-
- Lindley MC, Shen AK, Orenstein WA, Rodewald LE, Birkhead GS. Financing the delivery of vaccines to children and adolescents: challenges to the current system. Pediatrics. 2009;124 Suppl 5:S548–557. - PubMed
-
- Walker AT, Smith PJ, Kolasa M, Centers for Disease C, Prevention. Reduction of racial/ethnic disparities in vaccination coverage, 1995–2011. MMWR Suppl. 2014;63(1):7–12. - PubMed

